Cagrilintide acts via amylin/calcitonin receptors (satiety, delayed gastric emptying), whereas Retatrutide is a triple GLP-1/GIP/glucagon agonist
Supported by these data, novel therapeutic approaches for LRRK2-associated PD, as well as idiopathic PD, have focused on the development and use of LRRK2 kinase inhibitors (Fig
On the other hand, although statistical significance was not reached, the use of GLP-1RAs showed a trend towards a reduced risk of nine respiratory diseases (pneumonia, pulmonary fibrosis, dyspnea, acute respiratory failure, pleural effusion, COPD, sleep apnea syndrome, and pulmonary embolism)
Null mutations were made using the lambda red recombinase method to replace the open reading frame (Gebendorfer et al., 2012) with a chloramphenicol resistance cassette amplified from the pKD3 template (Datsenko and Wanner, 2000)